Call for applications
The fifth call for applications under the GACD banner focuses on scaling-up evidence-based interventions at the population level for the prevention or management of hypertension and/or diabetes.
The members of the GACD have agreed a common call text. However please note that some funders may have specific requirements in terms of scope and eligibility. Please refer to the funding agency specific information below or the respective agency’s website.
The call deadline is 10th September 2018 – 1600 BST. Argentina’s MINCyT/MINSAL, Australia’s NHMRC, Brazil’s FAPESP and Canada’s CIHR will be also be holding preliminary registration call phases.
Canada – 1st round deadline =12th July
Full application deadline = 10th September
Brazil – 1st round deadline = 10th August
Full application deadling = 10th September
Argentina – 1st round deadline = 15th June
Applicants notified = 15th July
Workshop for successful applicants = August
Full application deadline = 15th October
Australia – Applications due to NHMRC by 5pm (Australian Eastern Standard Time) on 15th August 2018
The GACD member agencies that will be funding research programmes under this call are detailed below. Some funders will be accepting applications through our common submission portal, which is intended to make the application experience more consistent and straightforward. Applicants will still need to choose the funding agency they are applying with, as funds will not be pooled across agencies. Note that while all funders are willing to consider proposals applying for co-funding from several funding agencies, some are actively encouraging co-funding proposals due to limited funds being available, please see below for further details.
Generally the country you are based in determines to which agency you can apply, however researchers from any country can apply to those GACD funding agencies that are able to fund internationally. However, they must do so as part of a team with researchers from the country of the respective GACD funding agency. Project teams must include researchers based in low- or middle-income countries, unless research involves vulnerable populations in high-income countries. Please consult each agency’s funding rules for details or contact us with any questions.
How to apply
If you are applying with the following funding agencies, please apply via the Common Submission Portal and read the guidance notes in the section ‘Funding agency specific information’ before proceeding with your application.
- Canadian Institutes for Health Research and International Development Research Centre, Canada
- Medical Research Council, United Kingdom
- Ministry of Health and Ministry of Science and Technology, Argentina
- Japan Agency for Medical Research and Development, Japan
- Indian Council of Medical Research, India
- São Paulo Research Foundation, Brazil
Applicants with the Australian National Health and Medical Research Council need to submit through the NHMRC website.
Funding agency specific information
CIHR-IDRC Canadian Institutes for Health Research and International Development Research Centre, Canada (agency website)
MINSAL Ministry of Health and Ministry of Science and Technology, Argentina (agency website)
AMED Japan Agency for Medical Research and Development, Japan (agency website)
NHMRC National Health and Medical Research Council, Australia (agency website)
UK MRC and NIHR Medical Research Council with National Institute for Health Research, UK (agency website)
CONACYT Consejo Nacional de Ciencia y Tecnología, Mexico
ICMR Indian Council of Medical Research, India
FAPESP São Paulo Research Foundation, Brazil (agency website) *Note: The FAPESP website offers a tool to help search for possible collaborators in your area of interest.
Please note: If applicants intend to apply for co-funding from agencies it is imperative that they contact agency representatives as soon as possible.
The European Commission’s call has already closed (Horizon 2020 programme).
Two webinars took place on the 8th May at 9:30-11am and 2-3:30pm (UK time).
Note on Organisational Implementation Partners
The fifth GACD funding call – Scaling-up of evidence-based health interventions at population level for the prevention and management of hypertension and/or diabetes – requires proposals to include the meaningful involvement of policymakers, intervention payers (not including research funding agencies), and implementers.
Such partners will be integral to the success and sustainability of the programme and it is essential that they are engaged early, and participate actively in the design of the research proposal. See the call text for further details on the expectations regarding engagement of implementation partners.
An ideal intervention payer to collaborate with is the government of the country or state where the intervention will take place. However, other partners are also possible. The GACD has developed a partnership with the World Bank as a possible intervention payer with a view to accelerating improvements in the performance of health systems through the generation and application of research evidence related to delivering of interventions for chronic diseases. Other development banks such as the Asian Development Bank and the Inter-American Development Bank, are also likely candidates. Additionally, foundations and other relevant funders may also be deemed strong partners, as long as their missions are aligned with the original objectives of this funding call.
Note to all applicants
Please note the following:
GACD Research Network
The GACD aims to coordinate research on chronic diseases at a global level in order to enhance knowledge exchange across individual projects, and to better understand the impact of socio-economic, cultural, geopolitical and policy factors on the effectiveness and scalability of interventions, so as to appropriately adapt health interventions to different geographical, economic and cultural settings. Research under GACD involves regular exchange of research findings and information across participating projects by means of cross-project working groups and annual joint meetings.
Applicants must budget for the costs of having two team members participate in one annual face-to-face meeting of the GACD Research Network (location to vary annually). Attendance at this meeting is mandatory for 2 team members, with at least one participant from the LMIC team where relevant. Teams are strongly encouraged to include one junior team member in each annual meeting.
The GACD funding agencies aim to harmonise the research and outcomes assessment of GACD funded projects in order to maximise the potential for learning across the network and the impact of the initiative as a whole. To this end:
• All funded teams are expected to use explicit indicators and measures of project context, reach, outcomes evaluation and scale-up potential in their plans and protocols;
• All teams should include Implementation Research outcomes (e.g. feasibility, fidelity and/or adaptation, spread and/or penetration, acceptability, sustainability, uptake, and cost effectiveness) and where relevant, include Service outcomes: (e.g. Efficiency, Safety, Effectiveness, Equity, Patient-centeredness, Timeliness);
• Shortly after notification of award, grantees will be given the opportunity to agree upon a common set of implementation and outcome indicators to employ across all projects, as well as sets of additional indicators that may be used by groups of similar types of projects.
• Applicants are encouraged to use the GACD Data Dictionary developed by GACD programmes
Implementation research focus
The GACD’s calls for applications have a specific focus on implementation research. We have put together a list of some resources that may help you in preparing your proposals, which are available on our Implementation Science page.